Alcoholism Stages – 3 Stages Of Alcoholism You Should Know

712

Alcoholism stages can be categorized into three stages of alcoholism – early stage, middle stage and end stage alcoholism or late stage alcoholism. Alcoholism stages generally take years to develop. Alcoholism is a disease where alcoholic beverage consumption is at a level that interferes with physical or mental health, and negatively impacts social, family or occupational responsibilities.

Consuming no more than one or two drinks per day for healthy men and a drink a day …

alcoholism stages,stages of alcoholism,alcohol abuse,alcoholism,alcoholism disease,alcohol,

Alcoholism stages can be categorized into three stages of alcoholism – early stage, middle stage and end stage alcoholism or late stage alcoholism. Alcoholism stages generally take years to develop. Alcoholism is a disease where alcoholic beverage consumption is at a level that interferes with physical or mental health, and negatively impacts social, family or occupational responsibilities.

Consuming no more than one or two drinks per day for healthy men and a drink a day for healthy non-pregnant women are generally considered acceptable alcohol consumption without health risks. However, as the amount or frequency of drinking increases, the earliest of the alcoholism stages can develop as a result.

Early Stages of Alcoholism

In the early alcoholism stages, a person begins to depend on alcohol to affect their mood. They drink for relief from problems, and they begin thinking more and more about alcohol. The person and others around them may not recognize that they are in the earliest of the stages of alcoholism. A gradual increase in tolerance happens, meaning, it takes increasing amounts of alcohol to achieve the desired mood-altering effects. Often, the person can consume large amounts of alcohol without appearing impaired.

At the early alcoholism stages, the body has adapted to increasing amounts of alcohol. In fact, how a person functions will likely be improved with drinking as blood alcohol levels rise. For example, they can think and talk normally or walk a straight line with no problem. However, with continued alcohol consumption over time, the body begins to lose its ability to deal with high alcohol levels. As this occurs, when the alcoholic stops drinking and their blood alcohol level decreases, their thinking, talking or walking functions deteriorate, and they are moving into the next of the stages of alcoholism.

Middle Alcoholism Stages

The need and desire to drink gradually becomes more intense. Drinking larger amounts and more often happens as well as drinking earlier in the day. The alcoholic is losing control over drinking, and the body is losing its ability to process alcohol like it did in the early stages of alcoholism. Their tolerance decreases as they become intoxicated more easily. Withdrawal symptoms begin to become more severe if alcohol is reduced.

The person may now secretly recognize there is a drinking problem, and others may begin to notice as well. Unfortunately, the alcoholic no longer can judge how much alcohol their body can handle. Typically, the drinker denies to themselves and others that alcohol is a problem so they won’t have to deal with their inner turmoil. Hangovers, blackouts and stomach problems can now be physical symptoms that occur on a regular basis.

End Stage Alcoholism

As alcoholism progresses, the alcoholic has become obsessed with drinking to the exclusion of nearly everything else. Everyone can tell there’s a major problem. During the late alcoholism stages, the mental and physical health of the alcoholic are seriously deteriorating. Many of the body’s organs have been damaged which lowers resistance to disease. Relationships at home or socially may have been severely damaged, and there can be mounting financial and legal problems due to the alcoholic’s powerlessness over alcohol.

Every alcoholic will suffer from malnutrition. Alcohol in large amounts interferes with the digestion process and the passage of nutrients from the intestines into the bloodstream. Liver function has been damaged, further limiting the conversion of nutrients into a usable form that the body can assimilate. The damaged cells are not receiving the needed nutrients, they cannot repair themselves and the damage continues. Nutritional deficiencies cause a host of related problems to become worse. For example, a vitamin B-1 deficiency common in alcoholics can result in loss of mental alertness and appetite, fatigue, confusion and emotional instability.

And if the alcoholic continues drinking, alcohol will cause the death of the alcoholic in one way or another. From suicide, accidents and related injuries to direct damage to the body’s organs and systems, death will likely be the final outcome of end stage alcoholism.

Are there warning signs of alcoholism? Yes! Understand the signs and symptoms that indicate that alcohol consumption is becoming or is already a problem. There are resources available in a variety of ways to help deal with alcoholism stages and the serious consequences of this disease.

Copyright 2006 InfoSearch Publishing

    'No new videos.'

An Innovative Treatment For Non-Hodgkin’s Lymphoma

419

Non-Hodgkin’s lymphoma is a slow-growing, life-threatening cancer of the immune system that develops when white blood cells grow uncontrollably in the lymph nodes.

An Innovative Treatment For Non-Hodgkin’s Lymphoma

Non-Hodgkin’s lymphoma is a slow-growing, life-threatening cancer of the immune system that develops when white blood cells grow uncontrollably in the lymph nodes. Each year in the U.S. alone, 55,000 new cases are diagnosed. Fortunately, novel, highly personalized treatments are being produced. With a recent medical breakthrough, patients can now receive individualized treatment that kills cancerous cells while sparing normal, healthy cells.

Traditional treatments usually consist of chemotherapy and monoclonal antibody drugs, which, along with targeting cancerous B-cells, kill healthy white blood cells that comprise a major component of the immune system.

Biovest International is one of a few companies working on patient-specific cancer vaccines. Biovest’s personalized therapeutic, BiovaxID, is currently being tested as a treatment for indolent (slow-growing) follicular B-cell non-Hodgkin’s lymphoma, which affects 12,500 new patients in the U.S. each year. The vaccine could eventually be used to treat other cancers.

Personalizing BiovaxID begins with a sampling of cancerous cells from a patient’s lymph nodes. On the surface of these cells are unique proteins, or antigens, detectable by the immune system. The doctor sends this sample of the patient’s cancer cells to Biovest’s laboratory in Worcester, Mass. Here, researchers mix the cells with another line of cells licensed from Stanford University. The cells fuse, releasing the antigen proteins.

As the patient undergoes chemotherapy to kill most of the cancer cells, Biovest collects and purifies the patient’s antigen proteins, which, after chemical modification, form the active ingredient of the custom vaccine. The individualized vaccine is then sent back to the doctor, who injects it into the patient five times over six months.

“Typical treatments for non-Hodgkin’s do not specifically target the tumor,” explains Dr. Carl M. Cohen, Biovest Chief Operating Officer. “Our vaccine trains the patient’s immune system to target a specific protein on the tumor cells-one found only on the tumor cells. BiovaxID only kills cancer cells. If you think of chemotherapy as a blunt instrument, our treatment is like tweezers.”

Results from a Biovest study of 20 patients, begun at the National Cancer Institute a decade ago, show a 95 percent survival rate. Forty-five percent are still in remission. According to historical data, only about half the patients would have survived with conventional treatments. None would still be in remission. (The Biovest-treated patients remained disease-free for a median of eight years.)

Currently, Biovest is enrolling patients for a large-scale study to be held at several major U.S. and European medical institutions. The trial will include 460 patients. Company officials hope to obtain FDA approval for the vaccine by 2008.

    'No new videos.'